|
||
J. Exp. Med.,
Volume 189, Number 2, January 18, 1999 347-358
By

From the * Julia McFarlane Diabetes Research Centre, Department of Microbiology and Infectious
Diseases, Faculty of Medicine, The University of Calgary, Calgary, Alberta, Canada T2N 4N1; the We have shown previously that the inactivation of macrophages in nonobese diabetic (NOD)
mice results in the prevention of diabetes; however, the mechanisms involved remain unknown. In this study, we found that T cells in a macrophage-depleted environment lost their
ability to differentiate into
Laboratory of Endocrinology, Institute for Medical Science, Department of Endocrinology and Metabolism,
School of Medicine, Ajou University, Suwon, Korea 442-749; and the § Department of Cell Biology & Immunology, Faculty of Medicine, Free University, Amsterdam, The Netherlands 1081 BT
cell-cytotoxic T cells, resulting in the prevention of autoimmune
diabetes, but these T cells regained their
cell-cytotoxic potential when returned to a macrophage-containing environment. To learn why T cells in a macrophage-depleted environment lose their ability to kill
cells, we examined the islet antigen-specific immune response and T cell activation in macrophage-depleted NOD mice. There was a shift in the immune
balance, a decrease in the T helper cell type 1 (Th1) immune response, and an increase in the
Th2 immune response, due to the reduced expression of the macrophage-derived cytokine
IL-12. As well, there was a deficit in T cell activation, evidenced by significant decreases in the
expression of Fas ligand and perforin. The administration of IL-12 substantially reversed the
prevention of diabetes in NOD mice conferred by macrophage depletion. We conclude that
macrophages play an essential role in the development and activation of
cell-cytotoxic T
cells that cause
cell destruction, resulting in autoimmune diabetes in NOD mice.
This article has been cited by other articles:
| TABLE OF CONTENTS |
|